Overview
An important compound functioning as a component of the coenzyme NAD. Its primary significance is in the prevention and/or cure of blacktongue and pellagra. Most animals cannot manufacture this compound in amounts sufficient to prevent nutritional deficiency and it therefore must be supplemented through dietary intake.
Indication
用于防治糙皮病等烟酸缺乏病，也用于防治心脏传导阻滞。
Associated Conditions
- Gastrointestinal insufficiency
- Hepatic Insufficiency
- Macrocytic anemia
- Secondary anemia
- Vitamin Deficiency
- Severe debilitation
Clinical Trials
View More Clinical Trials
Sign in to access the complete clinical trial database with detailed study information.
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2018/01/08 | Early Phase 1 | Completed | |||
2017/08/24 | Phase 2 | UNKNOWN | Second Xiangya Hospital of Central South University | ||
2017/05/02 | Phase 1 | Completed | |||
2017/02/23 | Phase 2 | Completed | |||
2015/04/15 | Phase 2 | UNKNOWN | Il Yeong Park, Ph.D. | ||
2014/10/07 | Phase 2 | Completed | |||
2014/08/11 | Phase 1 | Completed | |||
2012/05/02 | Phase 2 | UNKNOWN | |||
2012/03/02 | Phase 4 | Completed | |||
2011/06/08 | Phase 2 | Suspended |
FDA Drug Approvals
View More FDA Approvals
Sign in to access additional FDA-approved drug information with detailed regulatory data.
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Hillestad Pharmaceuticals USA | 10542-009 | ORAL | 20 mg in 1 1 | 10/24/2019 | |
| SLV PHARMACEUTICALS LLC DBA AUM PHARMACEUTICALS | 73317-8242 | ORAL | 20 mg in 1 1 | 9/25/2020 | |
| Hillestad Pharmaceuticals USA | 10542-012 | ORAL | 20 mg in 1 1 | 10/23/2019 | |
| Vivera Pharmaceuticals, Inc. | 72380-915 | ORAL | 60 mg in 1 1 | 2/10/2020 | |
| Amneal Pharmaceuticals LLC | 65162-668 | ORAL | 20 mg in 1 1 | 3/29/2022 | |
| Raw Materials International Overseas LLC | 69877-026 | INTRAMUSCULAR, INTRAVENOUS | 100 mg in 1 mL | 12/31/2015 | |
| Sincerus Florida, LLC | 72934-4054 | TOPICAL | 4 g in 100 g | 5/6/2019 | |
| Beijing Sea Heart International Science And Technology Co.,Ltd. | 85709-001 | TOPICAL | 0.2 mg in 100 mL | 5/20/2025 | |
| Sincerus Florida, LLC | 72934-1164 | TOPICAL | 4 g in 100 g | 5/3/2019 | |
| CarWin Pharmaceutical Associates, LLC | 15370-104 | ORAL | 5 mg in 1 1 | 1/10/2024 |
EMA Drug Approvals
View More EMA Approvals
Sign in to access additional EMA-approved drug information with detailed regulatory data.
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
View More HSA Approvals
Sign in to access additional HSA-approved drug information with detailed regulatory data.
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
View More NMPA Approvals
Sign in to access additional NMPA-approved drug information with detailed regulatory data.
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
View More PPB Approvals
Sign in to access additional PPB-approved drug information with detailed regulatory data.
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
View More TGA Approvals
Sign in to access additional TGA-approved drug information with detailed regulatory data.
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| Swisse Ultivite Children's Multivitamin | 276713 | Medicine | A | 6/17/2016 | |
| Pro Saffron Mood | 377510 | Medicine | A | 11/5/2021 | |
| METAGENICS FIBROPLEX PLUS ORANGE | 350478 | Medicine | A | 12/2/2020 | |
| Honey Spring NAD+Se | 367059 | Medicine | A | 5/25/2021 | |
| Swisse Men's Multivitamins | 351919 | Medicine | A | 12/18/2020 | |
| Swisse Ultivite Women's High Potency Multivitamin | 369430 | Medicine | A | 6/16/2021 | |
| Hydra Longevity Cellular Energy | 444673 | Medicine | A | 3/27/2024 | |
| NAD+NMN Plus | 373212 | Aus Nature Pharmaceuticals Pty Ltd | Medicine | A | 8/20/2021 |
| Daily Multi Multivitamin | 337216 | Medicine | A | 5/29/2020 | |
| Multivitamin + Minerals | 334495 | Medicine | A | 4/17/2020 |
Health Canada Drug Approvals
View More Health Canada Approvals
Sign in to access additional Health Canada approved drug information with detailed regulatory data.
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| HIGH POTENCY MULTI-VITAMIN & MIN PACK | nature's peak 2007 ltd | 00628166 | Capsule
,
Tablet - Oral | 150 MG / PCK | 12/31/1985 |
| FORMULA V S C TAB | creative nutrition canada corp. | 01963899 | Tablet - Oral | 2 MG / TAB | 12/31/1994 |
| HEMAREXIN LIQ | lab bio chimique inc.,division of technilab pharma inc. | 01922742 | Liquid - Oral | 5 MG / 5 ML | 12/22/1993 |
| FORMULA CW-CAPLET | body wise international llc | 02138549 | Tablet - Oral | 50 MG | 12/31/1995 |
| GRAND MASTER FORMULA TAB | nutrition for life international | 02053349 | Tablet - Oral | 5 MG | 12/30/1996 |
| CENTRUM JUNIOR COMPLETE (CHEWABLE TABLETS) | whitehall-robins inc. | 02240195 | Tablet - Oral | 20.0 MG / TAB | 5/25/2000 |
| BUGS BUNNY AND FRIENDS MULTIPLE VITAMINS | bayer inc consumer care | 02152894 | Tablet - Oral | 15 MG | 12/31/1996 |
| B-100 HI POTENCY B VITAMINS TAB | natrol, inc. | 02060256 | Tablet - Oral | 100 MG | 12/31/1994 |
| B-COMPLEX | enrich international | 02238709 | Tablet - Oral | 50 MG / TAB | 11/11/1999 |
| B 50 CAPSULES | rheingold food international ltd. | 00643041 | Capsule - Oral | 50 MG / CAP | 12/31/1987 |
CIMA AEMPS Drug Approvals
View More CIMA AEMPS Approvals
Sign in to access additional CIMA AEMPS approved drug information with detailed regulatory data.
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
View More Philippines FDA Approvals
Sign in to access additional Philippines FDA approved drug information with detailed regulatory data.
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
View More Saudi SFDA Approvals
Sign in to access additional Saudi SFDA approved drug information with detailed regulatory data.
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
View More Malaysia NPRA Approvals
Sign in to access additional Malaysia NPRA approved drug information with detailed regulatory data.
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
View More UK EMC Drug Information
Sign in to access additional UK EMC drug information with detailed pharmaceutical data.
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.